Royal Bank Of Canada Enanta Pharmaceuticals Inc Transaction History

Royal Bank Of Canada

$471 Billion
Q3 2024

A detailed history of Royal Bank Of Canada transactions in Enanta Pharmaceuticals Inc stock. As of the latest transaction made, Royal Bank Of Canada holds 2,156 shares of ENTA stock, worth $20,137. This represents 0.0% of its overall portfolio holdings.

Number of Shares

2,156

Previous 1,979 8.94%

Holding current value

$20,137

Previous $25,000 12.0%

% of portfolio

0.0%

Previous 0.0%

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	BUY	$10.05 - $16.54 $1,778 - $2,927	177 Added 8.94%	2,156 $22,000
Q2 2024 Aug 14, 2024	BUY	$11.43 - $17.02 $16,402 - $24,423	1,435 Added 263.79%	1,979 $25,000
Q1 2024 Nov 05, 2024	SELL	$10.08 - $17.46 $14,464 - $25,055	-1,435 Reduced 72.51%	544 $9,000
Q1 2024 May 15, 2024	SELL	$10.08 - $17.46 $61,961 - $107,326	-6,147 Reduced 91.87%	544 $9,000
Q4 2023 Feb 14, 2024	BUY	$8.18 - $10.78 $24,335 - $32,070	2,975 Added 80.06%	6,691 $62,000
Q3 2023 Nov 14, 2023	BUY	$11.09 - $22.13 $11,655 - $23,258	1,051 Added 39.44%	3,716 $41,000
Q2 2023 Aug 14, 2023	BUY	$20.68 - $39.85 $22,437 - $43,237	1,085 Added 68.67%	2,665 $57,000
Q1 2023 May 15, 2023	SELL	$38.82 - $54.59 $68,983 - $97,006	-1,777 Reduced 52.93%	1,580 $63,000
Q4 2022 Feb 14, 2023	BUY	$40.77 - $53.73 $108,122 - $142,491	2,652 Added 376.17%	3,357 $156,000
Q3 2022 Nov 14, 2022	BUY	$48.29 - $71.27 $6,181 - $9,122	128 Added 22.18%	705 $36,000
Q2 2022 Aug 15, 2022	SELL	$38.13 - $76.93 $41,599 - $83,930	-1,091 Reduced 65.41%	577 $27,000
Q1 2022 May 16, 2022	SELL	$56.06 - $74.11 $111,447 - $147,330	-1,988 Reduced 54.38%	1,668 $119,000
Q4 2021 Feb 14, 2022	BUY	$60.19 - $97.37 $74,394 - $120,349	1,236 Added 51.07%	3,656 $274,000
Q3 2021 Nov 15, 2021	BUY	$41.02 - $58.65 $41,471 - $59,295	1,011 Added 71.75%	2,420 $138,000
Q2 2021 Aug 16, 2021	BUY	$43.76 - $53.11 $61,657 - $74,831	1,409 New	1,409 $62,000

Others Institutions Holding ENTA

# of Institutions

110

Shares Held

21.1M

Call Options Held

4.8K

Put Options Held

4.6K

View Full List

About ENANTA PHARMACEUTICALS INC

Ticker ENTA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 20,724,900
Market Cap $194M
Description
Enanta Pharmaceuticals, Inc., a biotechnology company, discovers and develops small molecule drugs for the treatment of viral infections and liver diseases. Its research and development disease targets include respiratory syncytial virus, SARS-CoV-2, human metapneumovirus, and hepatitis B virus. The company has a collaborative development and li...

More about ENTA

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Royal Bank Of Canada, based on Form 13F filings with the SEC.

News

Stay updated on Royal Bank Of Canada with notifications on news.

Account

Royal Bank Of Canada Enanta Pharmaceuticals Inc Transaction History